Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Elsherbini

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Medrxiv : the Preprint Server for Health Sciences|September 3, 2025
Microbiota effects and predictors of Lactobacillus crispatus colonization after treatment with a vaginal live biotherapeutic: results from a randomized, double-blinded, placebo-controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Cell Host & Microbe|March 28, 2026
Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Donation strain engraftment demonstrates feasibility of vaginal microbiota transplantation to prevent recurrent bacterial vaginosisFatima A Hussain, Agnes Bergerat, Julia Kelly, et al.
The Lancet. Microbe|April 7, 2025
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trialAnke Hemmerling, Caroline M Mitchell, Suuba Demby, et al.
Cell|August 20, 2024
Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatmentMeilin Zhu, Matthew W Frank, Christopher D Radka, et al.
Cell Host & Microbe|March 19, 2026
VIBRANT: A phase 1 randomized trial of multi-strain vaginal L. crispatus live biotherapeutic products in people with bacterial vaginosisDisebo Potloane, Laura Symul, Sinaye Ngcapu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Medrxiv : the Preprint Server for Health Sciences|September 3, 2025
Microbiota effects and predictors of Lactobacillus crispatus colonization after treatment with a vaginal live biotherapeutic: results from a randomized, double-blinded, placebo-controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Cell Host & Microbe|March 28, 2026
Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trialSeth M Bloom, Laura Symul, Joseph Elsherbini, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Donation strain engraftment demonstrates feasibility of vaginal microbiota transplantation to prevent recurrent bacterial vaginosisFatima A Hussain, Agnes Bergerat, Julia Kelly, et al.
The Lancet. Microbe|April 7, 2025
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trialAnke Hemmerling, Caroline M Mitchell, Suuba Demby, et al.
Cell|August 20, 2024
Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatmentMeilin Zhu, Matthew W Frank, Christopher D Radka, et al.
Cell Host & Microbe|March 19, 2026
VIBRANT: A phase 1 randomized trial of multi-strain vaginal L. crispatus live biotherapeutic products in people with bacterial vaginosisDisebo Potloane, Laura Symul, Sinaye Ngcapu, et al.
Pageof 2